NOTE 13 – EARNINGS PER SHARE The following table illustrates the computation of basic and diluted earnings per share for the three and six months ended June 30, 2026 and 2025 (in thousands, except per share data): | | | | | | | | | | | | | | | For the Three Months Ended | | For the Six Months Ended | | | June 30, | | June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | Numerator (basic and diluted): | | | | | | | | | | | | | Net income | | $ | 715,064 | | $ | 668,595 | | $ | 1,319,245 | | $ | 1,207,080 | | | | | | | | | | | | | | Denominator: | | | | | | | | | | | | | Weighted-average common shares outstanding – basic | | | 825,197 | | | 854,003 | | | 831,853 | | | 856,768 | Effect of stock options (1) | | | 3,678 | | | 4,437 | | | 3,808 | | | 4,600 | Weighted-average common shares outstanding – assuming dilution | | | 828,875 | | | 858,440 | | | 835,661 | | | 861,368 | | | | | | | | | | | | | | Earnings per share: | | | | | | | | | | | | | Earnings per share-basic | | $ | 0.87 | | $ | 0.78 | | $ | 1.59 | | $ | 1.41 | Earnings per share-assuming dilution | | $ | 0.86 | | $ | 0.78 | | $ | 1.58 | | $ | 1.40 | | | | | | | | | | | | | | Antidilutive potential common shares not included in the calculation of diluted earnings per share: | | | | | | | | | | | | | Stock options (1) | | | 1,625 | | | 1,240 | | | 1,625 | | | 1,513 | Weighted-average exercise price per share of antidilutive stock options (1) | | $ | 91.22 | | $ | 82.24 | | $ | 90.96 | | $ | 78.64 |
| (1) | See Note 12 for further information concerning the terms of the Company’s share-based compensation plans. |
For the three and six months ended June 30, 2026 and 2025, the computation of diluted earnings per share did not include certain securities. These securities represent underlying stock options not included in the computation of diluted earnings per share, because the inclusion of such equity awards would have been antidilutive. See Note 9 for information concerning the Company’s subsequent share repurchases.
|